|
Volumn 3, Issue 2, 2003, Pages 93-94
|
The impact of genetic studies of type 2 diabetes on clinical practice
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ADENOSINE TRIPHOSPHATE;
CALPAIN;
GLUCOSE;
INSULIN;
NUCLEAR FACTOR I;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ANAMNESIS;
AWARENESS;
BIOCHEMISTRY;
CHROMOSOME 2Q;
CLINICAL PRACTICE;
DIAGNOSTIC PROCEDURE;
DIET RESTRICTION;
DRUG TARGETING;
EARLY DIAGNOSIS;
FAMILY HISTORY;
GENE MUTATION;
GENE SEQUENCE;
GENETIC ANALYSIS;
GENETIC DISORDER;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
GENOTYPE;
GENOTYPE ENVIRONMENT INTERACTION;
GLUCOSE TOLERANCE TEST;
HUMAN;
HUMAN GENOME;
HYPERGLYCEMIA;
INSULIN RELEASE;
INSULIN SENSITIVITY;
MOLECULAR CLONING;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
OBESITY;
PANCREAS ISLET CELL;
PHYSICAL EXAMINATION;
PROTEIN LOCALIZATION;
PROTEIN PROTEIN INTERACTION;
PROTEIN TARGETING;
RISK FACTOR;
SENSITIVITY AND SPECIFICITY;
ARTICLE;
GENETIC PREDISPOSITION;
GENETICS;
RISK ASSESSMENT;
UNITED STATES;
DIABETES MELLITUS, TYPE 2;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
PHYSICIAN'S PRACTICE PATTERNS;
RISK ASSESSMENT;
UNITED STATES;
VARIATION (GENETICS);
|
EID: 0038545493
PISSN: 15344827
EISSN: None
Source Type: Journal
DOI: 10.1007/s11892-003-0029-6 Document Type: Note |
Times cited : (3)
|
References (7)
|